{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:03:16Z","timestamp":1773874996184,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1038\/mt.2015.176","type":"journal-article","created":{"date-parts":[[2015,9,21]],"date-time":"2015-09-21T07:21:02Z","timestamp":1442820062000},"page":"240-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["AAV6-mediated Cardiac-specific Overexpression of Ribonucleotide Reductase Enhances Myocardial Contractility"],"prefix":"10.1016","volume":"24","author":[{"suffix":"Jr","given":"Stephen C","family":"Kolwicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy L","family":"Odom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah G","family":"Nowakowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid","family":"Moussavi-Harami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Reinecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen D","family":"Hauschka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles E","family":"Murry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory G","family":"Mahairas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Regnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2015.176_bib1","first-page":"e6","article-title":"Heart disease and stroke statistics\u20132013 update: a report from the American Heart Association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"key":"10.1038\/mt.2015.176_bib2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMcp0909392","article-title":"Clinical practice. Systolic heart failure","volume":"362","author":"McMurray","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2015.176_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"46","author":"Abraham","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/mt.2015.176_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10741-009-9153-y","article-title":"Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond","volume":"14","author":"Teerlink","year":"2009","journal-title":"Heart Fail Rev"},{"key":"10.1038\/mt.2015.176_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1172\/JCI62837","article-title":"Potential of gene therapy as a treatment for heart failure","volume":"123","author":"Hajjar","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2015.176_bib6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","article-title":"Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure","volume":"124","author":"Jessup","year":"2011","journal-title":"Circulation"},{"key":"10.1038\/mt.2015.176_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/CIRCRESAHA.113.302421","article-title":"Long-term effects of AAV1\/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality","volume":"114","author":"Zsebo","year":"2014","journal-title":"Circ Res"},{"key":"10.1038\/mt.2015.176_bib8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1021\/ml100138q","article-title":"Discovery of omecamtiv mecarbil the first, selective, small molecule activator of cardiac Myosin","volume":"1","author":"Morgan","year":"2010","journal-title":"ACS Med Chem Lett"},{"key":"10.1038\/mt.2015.176_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10741-009-9135-0","article-title":"A novel approach to improve cardiac performance: cardiac myosin activators","volume":"14","author":"Teerlink","year":"2009","journal-title":"Heart Fail Rev"},{"key":"10.1038\/mt.2015.176_bib10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(11)61219-1","article-title":"Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study","volume":"378","author":"Teerlink","year":"2011","journal-title":"Lancet"},{"key":"10.1038\/mt.2015.176_bib11","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1016\/S0006-3495(98)78013-0","article-title":"The effect of ATP analogs on posthydrolytic and force development steps in skinned skeletal muscle fibers","volume":"74","author":"Regnier","year":"1998","journal-title":"Biophys J"},{"key":"10.1038\/mt.2015.176_bib12","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1016\/S0006-3495(98)78012-9","article-title":"ATP analogs and muscle contraction: mechanics and kinetics of nucleoside triphosphate binding and hydrolysis","volume":"74","author":"Regnier","year":"1998","journal-title":"Biophys J"},{"key":"10.1038\/mt.2015.176_bib13","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/01.RES.86.12.1211","article-title":"2-deoxy-ATP enhances contractility of rat cardiac muscle","volume":"86","author":"Regnier","year":"2000","journal-title":"Circ Res"},{"key":"10.1038\/mt.2015.176_bib14","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1529\/biophysj.103.039123","article-title":"Cross-bridge versus thin filament contributions to the level and rate of force development in cardiac muscle","volume":"87","author":"Regnier","year":"2004","journal-title":"Biophys J"},{"key":"10.1038\/mt.2015.176_bib15","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1529\/biophysj.103.039131","article-title":"Cardiac length dependence of force and force redevelopment kinetics with altered cross-bridge cycling","volume":"87","author":"Adhikari","year":"2004","journal-title":"Biophys J"},{"key":"10.1038\/mt.2015.176_bib16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.yjmcc.2014.12.002","article-title":"2-Deoxy adenosine triphosphate improves contraction in human end-stage heart failure","volume":"79","author":"Moussavi-Harami","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/mt.2015.176_bib17","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.yjmcc.2011.08.026","article-title":"Upregulation of cardiomyocyte ribonucleotide reductase increases intracellular 2 deoxy-ATP, contractility, and relaxation","volume":"51","author":"Korte","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/mt.2015.176_bib18","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1073\/pnas.1220693110","article-title":"Transgenic overexpression of ribonucleotide reductase improves cardiac performance","volume":"110","author":"Nowakowski","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2015.176_bib19","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1158\/0008-5472.CAN-07-5873","article-title":"Broad overexpression of ribonucleotide reductase genes in mice specifically induces lung neoplasms","volume":"68","author":"Xu","year":"2008","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2015.176_bib20","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.yjmcc.2007.02.004","article-title":"Targeted high-efficiency, homogeneous myocardial gene transfer","volume":"42","author":"Sasano","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/mt.2015.176_bib21","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/hum.2011.042","article-title":"Transendocardial delivery of AAV6 results in highly efficient and global cardiac gene transfer in rhesus macaques","volume":"22","author":"Gao","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.176_bib22","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jtcvs.2011.08.048","article-title":"AAV6-\u03b2ARKct gene delivery mediated by molecular cardiac surgery with recirculating delivery (MCARD) in sheep results in robust gene expression and increased adrenergic reserve","volume":"143","author":"Katz","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1038\/mt.2015.176_bib23","doi-asserted-by":"crossref","first-page":"740653","DOI":"10.1155\/2012\/740653","article-title":"Gene transfer of heme oxygenase-1 using an adeno-associated virus serotype 6 vector prolongs cardiac allograft survival","volume":"2012","author":"Evans","year":"2012","journal-title":"J Transplant"},{"key":"10.1038\/mt.2015.176_bib24","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/eurheartj\/ehr447","article-title":"AAV6.\u03b2ARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model","volume":"34","author":"Raake","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1038\/mt.2015.176_bib25","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ejhf.270","article-title":"Ribonucleotide reductase-mediated increase in dATP improves cardiac performance via myosin activation in a large animal model of heart failure","volume":"17","author":"Kadota","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1038\/mt.2015.176_bib26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/sj.mt.6300322","article-title":"A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner","volume":"16","author":"Ghosh","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.176_bib27","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1089\/hum.2009.058","article-title":"Systemic Trans-splicing adeno-associated viral delivery efficiently transduces the heart of adult mdx mouse, a model for duchenne muscular dystrophy","volume":"20","author":"Ghosh","year":"2009","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.176_bib28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/mt.2010.205","article-title":"Gene therapy of mdx mice with large truncated dystrophins generated by recombination using rAAV6","volume":"19","author":"Odom","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.176_bib29","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/onc.2014.155","article-title":"Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies","volume":"34","author":"Aye","year":"2015","journal-title":"Oncogene"},{"key":"10.1038\/mt.2015.176_bib30","first-page":"2698","article-title":"Molecular cloning of the cDNA for a mutant mouse ribonucleotide reductase M1 that produces a dominant mutator phenotype in mammalian cells","volume":"8","author":"Caras","year":"1988","journal-title":"Mol Cell Biol"},{"key":"10.1038\/mt.2015.176_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev.biochem.67.1.71","article-title":"Ribonucleotide reductases","volume":"67","author":"Jordan","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1038\/mt.2015.176_bib32","doi-asserted-by":"crossref","first-page":"33021","DOI":"10.1074\/jbc.M005337200","article-title":"Cross-talk between the allosteric effector-binding sites in mouse ribonucleotide reductase","volume":"275","author":"Reichard","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2015.176_bib33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nsmb.2007","article-title":"Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization","volume":"18","author":"Fairman","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"10.1038\/mt.2015.176_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.yjmcc.2010.10.025","article-title":"Calcium binding kinetics of troponin C strongly modulate cooperative activation and tension kinetics in cardiac muscle","volume":"50","author":"Kreutziger","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/mt.2015.176_bib35","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/S0006-3495(99)77418-7","article-title":"Regulation of skeletal muscle tension redevelopment by troponin C constructs with different Ca2+ affinities","volume":"76","author":"Regnier","year":"1999","journal-title":"Biophys J"},{"key":"10.1038\/mt.2015.176_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpj.2012.11.125","article-title":"2-deoxy-ATP alters myosin structure to enhance cross-bridge cycling and improve cardiac function","volume":"104","author":"Nowakowski","year":"2013","journal-title":"Biophys J"},{"key":"10.1038\/mt.2015.176_bib37","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1161\/01.RES.87.9.768","article-title":"Strongly binding myosin crossbridges regulate loaded shortening and power output in cardiac myocytes","volume":"87","author":"McDonald","year":"2000","journal-title":"Circ Res"},{"key":"10.1038\/mt.2015.176_bib38","doi-asserted-by":"crossref","first-page":"H1055","DOI":"10.1152\/ajpheart.00667.2001","article-title":"Cooperative activation in cardiac muscle: impact of sarcomere length","volume":"282","author":"Dobesh","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1038\/mt.2015.176_bib39","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/HYPERTENSIONAHA.108.122333","article-title":"Onset of experimental severe cardiac fibrosis is mediated by overexpression of Angiotensin-converting enzyme 2","volume":"53","author":"Masson","year":"2009","journal-title":"Hypertension"},{"key":"10.1038\/mt.2015.176_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/9780470942390.mo100130","article-title":"Echocardiography in Mice","volume":"1","author":"Gao","year":"2011","journal-title":"Curr Protoc Mouse Biol"},{"key":"10.1038\/mt.2015.176_bib41","doi-asserted-by":"crossref","first-page":"H1525","DOI":"10.1152\/ajpheart.00890.2014","article-title":"Best anesthetics for assessing left ventricular systolic function by echocardiography in mice","volume":"308","author":"Pachon","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1038\/mt.2015.176_bib42","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.yjmcc.2014.04.010","article-title":"Cell-based delivery of dATP via gap junctions enhances cardiac contractility","volume":"72","author":"Lundy","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/mt.2015.176_bib43","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1083\/jcb.107.2.573","article-title":"Analysis of the upstream regions governing expression of the chicken cardiac troponin T gene in embryonic cardiac and skeletal muscle cells","volume":"107","author":"Mar","year":"1988","journal-title":"J Cell Biol"},{"key":"10.1038\/mt.2015.176_bib44","doi-asserted-by":"crossref","first-page":"30595","DOI":"10.1016\/S0021-9258(18)43855-0","article-title":"Characterization of cis-regulating elements and trans-activating factors of the rat cardiac troponin T gene","volume":"269","author":"Wang","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2015.176_bib45","doi-asserted-by":"crossref","first-page":"e18556","DOI":"10.1371\/journal.pone.0018556","article-title":"High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.176_bib46","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1128\/JVI.75.14.6615-6624.2001","article-title":"Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors","volume":"75","author":"Halbert","year":"2001","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.176_bib47","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ymthe.2004.07.016","article-title":"Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6","volume":"10","author":"Blankinship","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.176_bib48","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1085","article-title":"Systemic delivery of genes to striated muscles using adeno-associated viral vectors","volume":"10","author":"Gregorevic","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/mt.2015.176_bib49","first-page":"e2069","article-title":"Assessment of cardiac function and energetics in isolated mouse hearts using 31P NMR spectroscopy","volume":"42","author":"Kolwicz Jr","year":"2010","journal-title":"J Vis Exp"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616303306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616303306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:49:50Z","timestamp":1761500990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616303306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1525001616303306"],"URL":"https:\/\/doi.org\/10.1038\/mt.2015.176","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV6-mediated Cardiac-specific Overexpression of Ribonucleotide Reductase Enhances Myocardial Contractility","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2015.176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}